SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Nasus Pharma Appoints Nir Sassi as CFO

Nir Sassi’s appointment as chief financial officer took effect November 11, 2026. Nasus Pharma plans to begin its NS002 pivotal Phase 3 study in Q4 2026 and report topline data in Q1 2027.

NSRX

Related stories